Antibiotic Limitations: Resistance, Side Effects, and Stewardship
Antibiotics revolutionized medicine but face critical limitations:
- Resistance: Overuse/misuse selects resistant mutants; global threat (MRSA, VRE, CRE, MDR‑TB).
- Spectrum mismatch: Narrow vs. broad; empiric therapy may miss pathogen.
- Adverse effects: GI upset, C. difficile colitis, allergy, nephro/hepatotoxicity, QT prolongation, tendon rupture (fluoroquinolones).
- Microbiome disruption: Dysbiosis → secondary infections, metabolic/immune consequences.
- Drug interactions: e.g., macrolides + statins, rifampin enzyme induction.
- Narrow therapeutic index: Aminoglycosides, vancomycin require therapeutic drug monitoring.
- Cost & access: New agents expensive; shortages occur.
- Diagnostic delay: Empiric antibiotics may mask cultures.
- Environmental contamination: Agricultural runoff selects resistance in wildlife.
- Overprescribing: Viral URIs, asymptomatic bacteriuria.
Antimicrobial stewardship (right drug, dose, duration, de‑escalation) preserves efficacy.
Prescription Medications - Related Articles
- APO vs. NOVO Metoprolol: Understanding Medication Variations
- Acetaminophen vs. Morphine: Distinct Mechanisms, Uses, and Safety Profiles
- Light-Sensitive Medications: A Comprehensive Guide to Storage
- USMC Regulations on Anti-Acid Tablets: What You Need to Know
- Managing Augmentin Side Effects: What You Need to Know
- Product Monograph: Definition, Purpose & Regulatory Information
- Methylin ER (Methylphenidate): Understanding Extended-Release Options
